Openly accessible

Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015

Wang, H, Wolock, TM, Carter, A, Nguyen, G, Kyu, HH, Gakidou, E, Hay, SI, Msemburi, W, Coates, MM, Mooney, MD, Fraser, MS, Sligar, A, Larson, HJ, Friedman, J, Brown, A, Dandona, L, Fullman, N, Haagsma, J, Khalil, I, Lim, SS, Mikesell, J, Mokdad, AH, Moradi-Lakeh, M, Pearson, K, Silpakit, B, Sorensen, MJD, Temesgen, AM, Vollset, SE, Zoeckler, L, Murray, CJL, Alfonso-Cristancho, R, Harun, KM, Prokop, DM, Mills, EJ, Trickey, A, Ajala, ON, Bärnighausen, T, Ding, EL, Farvid, MS, Thorne-Lyman, AL, Won, S, Fitchett, JRA, Salomon, J, Abajobir, AA, Hoy, DG, Alam, NKM, Abate, KH, Ghiwot, TT, Gebremedhin, AT, Abbas, KM, Abd El Razek, MM, Abd-Allah, F, Abdulle, AM, Abera, SF, Melaku, YA, Tesfay, Fisaha, Abyu, GY, Bayou, TA, Betsu, BD, Gebru, AA, Hailu, GB, Tekle, T, Yalew, AZ, Yebyo, HG, Abubakar, I, Aldridge, RW, Abu-Raddad, LJ, Abu-Rmeileh, NME, Adebiyi, AO, Adedeji, IA, Adelekan, AL, Ojelabi, FA, Adofo, K, Adou, AK, Akinyemiju, TF, Schwebel, DC, Singh, JA, Akseer, N, Al Lami, FH, Al-Aly, Z, Alam, K, Weintraub, RG, Chiang, PP, Meretoja, A, Lopez, AD, Wijeratne, T, Driscoll, TR, Kemp, AH, Leigh, J, Mekonnen, Alemayehu, Karema, CK, Alasfoor, D, Aldhahri, SFS, Terkawi, AS, Alegretti, MA, Aleman, AV, Alemu, ZA, Cooper, C and Deribew, A 2016, Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015, The Lancet HIV, vol. 3, no. 8, pp. e361-e387, doi: 10.1016/S2352-3018(16)30087-X.

Attached Files
Name Description MIMEType Size Downloads
mekonnen-estimatesofglobalregional-2016.pdf Published version application/pdf 12.90MB 12

Title Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
Author(s) Wang, H
Wolock, TM
Carter, A
Nguyen, G
Kyu, HH
Gakidou, E
Hay, SI
Msemburi, W
Coates, MM
Mooney, MD
Fraser, MS
Sligar, A
Larson, HJ
Friedman, J
Brown, A
Dandona, L
Fullman, N
Haagsma, J
Khalil, I
Lim, SS
Mikesell, J
Mokdad, AH
Moradi-Lakeh, M
Pearson, K
Silpakit, B
Sorensen, MJD
Temesgen, AM
Vollset, SE
Zoeckler, L
Murray, CJL
Alfonso-Cristancho, R
Harun, KM
Prokop, DM
Mills, EJ
Trickey, A
Ajala, ON
Bärnighausen, T
Ding, EL
Farvid, MS
Thorne-Lyman, AL
Won, S
Fitchett, JRA
Salomon, J
Abajobir, AA
Hoy, DG
Alam, NKM
Abate, KH
Ghiwot, TT
Gebremedhin, AT
Abbas, KM
Abd El Razek, MM
Abd-Allah, F
Abdulle, AM
Abera, SF
Melaku, YA
Tesfay, FisahaORCID iD for Tesfay, Fisaha
Abyu, GY
Bayou, TA
Betsu, BD
Gebru, AA
Hailu, GB
Tekle, T
Yalew, AZ
Yebyo, HG
Abubakar, I
Aldridge, RW
Abu-Raddad, LJ
Abu-Rmeileh, NME
Adebiyi, AO
Adedeji, IA
Adelekan, AL
Ojelabi, FA
Adofo, K
Adou, AK
Akinyemiju, TF
Schwebel, DC
Singh, JA
Akseer, N
Al Lami, FH
Al-Aly, Z
Alam, K
Weintraub, RG
Chiang, PP
Meretoja, A
Lopez, AD
Wijeratne, T
Driscoll, TR
Kemp, AH
Leigh, J
Mekonnen, AlemayehuORCID iD for Mekonnen, Alemayehu
Karema, CK
Alasfoor, D
Aldhahri, SFS
Terkawi, AS
Alegretti, MA
Aleman, AV
Alemu, ZA
Cooper, C
Deribew, A
Journal name The Lancet HIV
Volume number 3
Issue number 8
Start page e361
End page e387
Total pages 27
Publisher Elsevier
Place of publication Amsterdam, The Netherlands
Publication date 2016-08-01
ISSN 2352-3018
Keyword(s) Science & Technology
Life Sciences & Biomedicine
Infectious Diseases
GBD 2015 HIV Collaborators
Summary Background Timely assessment of the burden of HIV/AIDS is essential for policy setting and programme evaluation. In this report from the Global Burden of Disease Study 2015 (GBD 2015), we provide national estimates of levels and trends of HIV/AIDS incidence, prevalence, coverage of antiretroviral therapy (ART), and mortality for 195 countries and territories from 1980 to 2015. Methods For countries without high-quality vital registration data, we estimated prevalence and incidence with data from antenatal care clinics and population-based seroprevalence surveys, and with assumptions by age and sex on initial CD4 distribution at infection, CD4 progression rates (probability of progression from higher to lower CD4 cell-count category), on and off antiretroviral therapy (ART) mortality, and mortality from all other causes. Our estimation strategy links the GBD 2015 assessment of all-cause mortality and estimation of incidence and prevalence so that for each draw from the uncertainty distribution all assumptions used in each step are internally consistent. We estimated incidence, prevalence, and death with GBD versions of the Estimation and Projection Package (EPP) and Spectrum software originally developed by the Joint United Nations Programme on HIV/AIDS (UNAIDS). We used an open-source version of EPP and recoded Spectrum for speed, and used updated assumptions from systematic reviews of the literature and GBD demographic data. For countries with high-quality vital registration data, we developed the cohort incidence bias adjustment model to estimate HIV incidence and prevalence largely from the number of deaths caused by HIV recorded in cause-of-death statistics. We corrected these statistics for garbage coding and HIV misclassification. Findings Global HIV incidence reached its peak in 1997, at 3·3 million new infections (95% uncertainty interval [UI] 3·1–3·4 million). Annual incidence has stayed relatively constant at about 2·6 million per year (range 2·5–2·8 million) since 2005, after a period of fast decline between 1997 and 2005. The number of people living with HIV/AIDS has been steadily increasing and reached 38·8 million (95% UI 37·6–40·4 million) in 2015. At the same time, HIV/AIDS mortality has been declining at a steady pace, from a peak of 1·8 million deaths (95% UI 1·7–1·9 million) in 2005, to 1·2 million deaths (1·1–1·3 million) in 2015. We recorded substantial heterogeneity in the levels and trends of HIV/AIDS across countries. Although many countries have experienced decreases in HIV/AIDS mortality and in annual new infections, other countries have had slowdowns or increases in rates of change in annual new infections. Interpretation Scale-up of ART and prevention of mother-to-child transmission has been one of the great successes of global health in the past two decades. However, in the past decade, progress in reducing new infections has been slow, development assistance for health devoted to HIV has stagnated, and resources for health in low-income countries have grown slowly. Achievement of the new ambitious goals for HIV enshrined in Sustainable Development Goal 3 and the 90-90-90 UNAIDS targets will be challenging, and will need continued efforts from governments and international agencies in the next 15 years to end AIDS by 2030. Funding Bill & Melinda Gates Foundation, and National Institute of Mental Health and National Institute on Aging, National Institutes of Health.
Language eng
DOI 10.1016/S2352-3018(16)30087-X
Indigenous content off
Field of Research 11 Medical and Health Sciences
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2016, The Author(s)
Free to Read? Yes
Use Rights Creative Commons Attribution licence
Persistent URL

Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 360 times in TR Web of Science
Scopus Citation Count Cited 369 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 22 Abstract Views, 14 File Downloads  -  Detailed Statistics
Created: Sat, 09 May 2020, 10:32:51 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact